Imaging Informatics Solutions Provider ClearCanvas Debuts Vendor Neutral PACS Cleome

Monday, September 16, 2013

ClearCanvas introduces its unique new vendor neutral PACS, Cleome, to its portfolio of commercial products. This web-based breakthrough solution features fast diagnostic viewing of all medical images using zero-footprint HTML5, anytime, anywhere.  

Cleome pairs the vendor neutral Cleome ImageServer for image archiving, retrieval and distribution with the seamlessly integrated, fast and easy to use, Cleome Webstation DX, and Cleome Webstation for referring physicians.

Designed to accelerate efficiency and quality of patient care, Cleome can be incorporated into your current IT architecture to propel your service with a platform that defines the next generation of imaging innovation. With open source roots, the extensible and open architecture Cleome ImageServer works with any hardware and all modality manufacturers creating a truly vendor neutral environment. Fitting your needs both today and tomorrow, Cleome is easily scalable from a single user to a true enterprise wide deployment.  

The zero footprint Cleome Webstation DX is platform independent enabling users the flexibility of viewing diagnostic images from a Mac or PC product and through your browser of choice including Chrome, Internet Explorer, Firefox or Safari. The simplicity of single sign on gives the user their customized toolsets independent of where they are accessing the images. Powered with a proprietary web engine, the intuitive fully featured viewer is easy to learn and delivers images with unprecedented speed to efficiently review cases.

"Having fast availability of diagnostic images through a zero footprint web browser has made it easier than ever before to access cases from anywhere," says Dr. Jeffrey Robinson, Radiologist, Clear Review, Inc., Seattle, WA.

Cleome Webstation closes the patient care loop by giving physicians across the enterprise easy access to studies with an intuitive easy to navigate viewer that displays images and associated reports.

ClearCanvas CEO Clinton Chau comments, "It is critically important for clinicians today to have fast access to even the highest volume studies on the platform of their choice to ultimately deliver the best patient care possible. We invite you to see how Cleome solves the need for both diagnostic accessibility and enterprise interoperability in the fastest, most streamlined integrated solution on the market."

Cleome is cleared by the FDA, Health Canada and is CE-marked.

 

ClearCanvas Platform Powers Tumor Imaging Metrics Core Measurements

Tuesday, November 27, 2012

ClearCanvas Inc., an innovative medical imaging informatics company, today announced the roll-out of the integration between the ClearCanvas open source picture archiving and communication system (PACS) and workstation and the Tumor Imaging Metrics Core (TIMC) clinical trials system developed at Massachusetts General Hospital for use in managing clinical trials across multiple institutions.

ClearCanvas' software development platform allows innovators to easily build specialized plug-ins to extend the functionality of their products. Because the platform provides all the required image visualization and management services, innovators can focus on the specifics of their respective core competencies.

"We could not find off-the-shelf commercial software that met our requirements, so we decided to build custom tools designed to our own specifications for making protocol-driven measurements for cancer clinical trials and to electronically link these measurements and images to the web-based workflow management and reporting system that we developed for our Tumor Imaging Metrics Core," said Gordon J. Harris, PhD, co-director of TIMC.  "By creating plug-in software modules within an open source radiology imaging environment, we were able to build our own custom-designed measurement tools and upload results directly to our web-based tracking system to create a comprehensive and integrated solution that can serve as a common platform across multiple cancer centers."

Harris said that with an integrated system that manages all aspects of clinical trials measurements, the TIMC has been able to provide efficient and reliable tumor measurements, with rapid turnaround time, across multiple hospitals. TIMC, which is used by hospitals comprising the Dana-Farber/Harvard Cancer Center, can deliver improved quality tumor metrics for oncologists, with less effort and disruption for oncology coordinators and radiologists, helping ensure that patients are appropriately qualified for participation criteria in clinical trials.

"We are very excited about what the TIMC has done," says Norman Young, CEO of ClearCanvas. "This integration has demonstrated exactly what the ClearCanvas platform is intended for. It has enabled a team of innovators to quickly and easily build and integrate new specialized tools without worrying about building the PACS to host them, saving time and resources."